Results 201 to 210 of about 113,181 (243)

Trends in clinical intervention practice for preventing mother-to-child transmission of hepatitis B virus in Guangdong Province, 2021-2023. [PDF]

Hum Vaccin Immunother
Gao S, Xie T, Cai M, Su M, Zhao T, Zhang X, Zhang S, Wang M, Xu Q, Cheng Y, Cui F, Liu F.   +11 more
europepmc   +1 more source

Prevalence of Active HCV Infection in Spain in 2022 Using Multiparameter Evidence Synthesis

Journal of Viral Hepatitis, Volume 33, Issue 4, April 2026.
ABSTRACT Hepatitis C virus (HCV) remains a major public health concern worldwide. Spain has implemented large‐scale direct‐acting antiviral (DAA) treatment programs, yet the prevalence of active HCV infection (aHCV) and its trends over time remain incompletely characterised.
Christos Thomadakis, Ilias Gountas, Konstantinos Gountas, Nestor Nuño, Begoña Brime, Rosario Sendino, Agustín Albillos, María Buti, Javier Crespo, Juan Berenguer, Sonia Alonso, Alberto Díaz de Santiago, Victoria Hernando, Montserrat Laguno, Sabela Lens, Moisés Diago, Maria Luisa Montes, Javier García‐Samaniego, Luis Morano, Juan Luis Moreno, Jordi Navarro, Manuel Romero‐Gómez, Laura Santos, Raúl Soriano, Erika Duffell, Asuncion Diaz, Julia del Amo, Georgios Nikolopoulos   +27 more
wiley   +1 more source

Hepatitis B immunity and vaccine completion among adults at increased risk for hepatitis B infection in Zambia. [PDF]

PLoS One
Syabbalo E, Mpisa S, Vinikoor MJ, Wamundila M, Munalula L, Musonda T, Phiri R, Kelly P, Thio C, Thomas DL, Sinkala E.   +10 more
europepmc   +1 more source

Detection and characterization of Hepatitis B virus double-stranded linear DNA-derived covalently closed circular DNA in chronic hepatitis B patients. [PDF]

PLoS Pathog
Liu HN, Kim E, Sun N, Wang Z, Nguyen T, Shieh FS, Liu Y, Ghany MG, Chung RT, Sterling RK, Lin SY, Guo H, Lau DTY, Su YH.   +13 more
europepmc   +1 more source

Methyl-CpG-binding domain protein 2 epigenetically represses monocyte HLA-DR expression and promotes immune paralysis in HBV-related acute-on-chronic liver failure. [PDF]

Front Immunol
Liu X, Jiang X, Zhang X, Hu Q, Yu X, Sun J, Lu M, Zhang J, Huang Y.   +8 more
europepmc   +1 more source

Correction: Comparison of HBV-specific T cell reactivity across the pregnant, postpartum and non-pregnant women with chronic HBV infection. [PDF]

Front Immunol
Wang G, Yue F, Zhang Z, Wu Y, Ji R, Zhou G, Ji Y, Shen C.   +7 more
europepmc   +1 more source

Postpartum TDF continuation in high HBV-DNA mothers: safety for breastfeeding and enhanced infant immunity. [PDF]

Front Pediatr
Han D, Gen X, Wang W, Du J, Chu W, Xiao H, Zhang Y.   +6 more
europepmc   +1 more source

Reconsidering antiviral prophylaxis in HBsAg-negative, anti-HBc-positive patients treated with rituximab. [PDF]

Hepatol Commun
Papatheodoridis G, Hwang J.
europepmc   +1 more source

People living with HIV co-infected with HBV at the Nkembo Outpatient Treatment Center, Gabon: prevalence and associated factors. [PDF]

Front Public Health
Moukanda-Ifoundou R, Massolou-Outata R, Mangala C, Mombo-Maganga C, Matsomo-Kombet GE, Boukandou-Bina JA, Yenze-Mouelé D, Moutsinga A, Okolongo-Mayani SC, Maulot-Bangola D, Ouambo H, Fokam J, Ongali B, Lemamy GJ.   +13 more
europepmc   +1 more source

Evidence for a relationship between concentrations of nucleos/tide analogue agents and treatment outcome in chronic hepatitis B infection: A systematic review

Sukali G, Anderson M, Mohammed KS, Biggs P, Delphin M, Redmond JM, Maponga T, Govender K, Amponsah SK, Alffenaar J, Waitt C, Iwuji C, Matthews PC.   +12 more
europepmc   +1 more source